Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD

NCT05075057 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Chronic Bronchitis
Copd

Interventions

BIOLOGICAL: Inactivated COVID-19 vaccine

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]